Systemic lupus erythematosus. Systemic lupus erythematosus (SLE)
Conditions
Interventions
Intervention 1: Intervention group: Implementation of commitment and acceptance therapy in most of 12 sessions, weekly and Individual. Intervention 2: Control group: Implementation of commitment and
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: The patient is diagnosed based on the scale of chrysteria SLICC 2013 and according to the criteria of the activity of lupus BILAG and the clinical judgment of a rheumatologist with lupus and be included in group B to D (mild to moderate disease activity). Age between 20 and 60 years Lack of other chronic physical illnesses such as diabetes and thyroid disorders or other physical illnesses that are included in the patient's case according to a physician's report Non -pregnancy Failure to engage the central nervous system as a result of lupus disease based on disease activity index BILAG Lack of severe mental illnesses including schizophrenic spectrum disorders, type 1 bipolar and severe personality disorders other than cluster C disorders based on scale SCID_5_CV Having a minimum education of 8 class literacy Announcement of consent to participate in the research Failure to attend psychotherapy sessions from six months before starting treatment
Exclusion criteria
Exclusion criteria: Absence of more than two sessions in treatment The subject's unwillingness to continue the treatment process Recurrence and hospitalization during the intervention period Attend psychotherapy sessions and other support groups at the same time as the research period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduce stress based on DASS 21 questionnaire Reduce depression based on DASS 21 questionnaire Reduce anxiety based on DASS 21 questionnaire Increase the quality of sleep based on the PSQI questionnaire Increase the quality of life based on the LUPUS - PRO 1.7 questionnaire. Timepoint: before intervention begins, after intervention and two months after intervention. Method of measurement: DASS 21 questionnaire PSQI questionnaire LUPUS - PRO 1.7 questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduce the levels of ComplementsC3,C4,CH50 Reducing the levels of Anti -ds DNA. Timepoint: Before the intervention begins, after the intervention and two months after the intervention. Method of measurement: Device IMM.Turbid Device ELISA. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Youkhabeh.Mohammadian
Kermanshah University of Medical Sciences
Outcome results
None listed